| Geriatrics |
0 |
1 |
| Breast Cancer |
0 |
0.5 |
| Pain Management |
0 |
0.39 |
| Anticoagulation Therapy |
0 |
0.38 |
| Clinical Guidelines |
0 |
0.38 |
| Thromboembolism |
0 |
0.37 |
| Prostate Cancer |
0 |
0.3 |
| Type 2 Diabetes Mellitus |
0 |
0.28 |
| Cardiovascular Risk Management |
0 |
0.21 |
| Healthcare and Medical Technology |
0 |
0.21 |
| Aspirin |
0 |
0.19 |
| Cancer |
0 |
0.19 |
| Clinical Research |
0 |
0.19 |
| Estrogen |
0 |
0.19 |
| Nonsteroidal Anti-Inflammatory Agents |
0 |
0.19 |
| Sulfonylureas |
0 |
0.19 |
| Testosterone |
0 |
0.19 |
| Breast Cancer History |
0 |
0.18 |
| Atrial Fibrillation |
0 |
0.17 |
| Cerebrovascular Accident |
0 |
0.17 |
| Hypoglycemia |
0 |
0.13 |
| Pain |
0 |
0.13 |
| Prostate |
0 |
0.13 |
| Steroids |
0 |
0.13 |
| Venous Thromboembolism (VTE) |
0 |
0.13 |
| Renal Failure |
0 |
0.12 |
| Hypogonadism |
0 |
0.07 |
| Revenue and Practice Management |
0 |
0.07 |
| Breast |
0 |
0.06 |
| Cardiovascular disease |
0 |
0.06 |
| Dementia |
0 |
0.06 |
| Encephalopathy |
0 |
0.06 |
| Heart |
0 |
0.06 |
| Interprofessional Continuing Education |
0 |
0.06 |
| Pharmaceutical Services Insurance |
0 |
0.06 |
| Proton Pump Inhibitor |
0 |
0.06 |
| SGLT2 Inhibitor |
0 |
0.06 |
| Vagina |
0 |
0.06 |